Pacira Pharmaceuticals, Inc. Human Resources Contracts & Agreements
56 Contracts & Agreements
- Bonus & Incentive Agreements (14 contracts)
- Compensation Agreements (2)
- Consulting Agreements (6)
- Employment Agreements (33)
- Retirement Agreements (1)
- Amended and Restated Executive Employment Agreement, dated as of November 4, 2024, by and between Pacira Pharmaceuticals, Inc. and Lauren Riker (Filed With SEC on November 6, 2024)
- Amendment No. 3 to Employment Agreement, dated as of (Filed With SEC on November 6, 2024)
- Amendment No. 1 to Executive Employment, dated as of (Filed With SEC on November 6, 2024)
- Amendment No. 1 to Executive Employment Agreement, dated as of (Filed With SEC on November 6, 2024)
- Non-Healthcare Professional Consulting Agreement, effective October 1, 2024, between the Registrant and Charles. A. Reinhart, III (Filed With SEC on November 6, 2024)
- Amendment No. 3 to Employment Agreement, dated August 16, 2024, between the Registrant and Lauren Riker (Filed With SEC on November 6, 2024)
- Amendment No. 2 to Employment Agreement, dated June 30, 2015, between the Registrant and Lauren Riker (Filed With SEC on November 6, 2024)
- Fifth Amendment to Consulting Agreement, dated June 12, 2024, between the Registrant and Gary Pace (Filed With SEC on July 30, 2024)
- Form of Restricted Stock Unit Award Agreement (Non-Employee Directors) under the Amended and Restated 2011 Stock Incentive Plan for grants made prior to February 1, 2022 (Filed With SEC on February 29, 2024)
- Form of Restricted Stock Unit Award Agreement (Employees) under the Amended and Restated 2011 Stock Incentive Plan for grants made prior to February 1, 2022 (Filed With SEC on February 29, 2024)
- Executive Employment Agreement, dated December 20, 2023, by and between Pacira Pharmaceuticals, Inc. and Frank Lee (Filed With SEC on December 21, 2023)
- Transition and Retirement Agreement, dated September 20, 2023, between Pacira BioSciences, Inc. and David Stack (Filed With SEC on September 26, 2023)
- Executive Employment Agreement, dated December 6, 2016, between the Registrant and Anthony Molloy (Filed With SEC on May 3, 2023)
- Executive Employment Agreement, dated June 17, 2019, between the Registrant and Daryl Gaugler (Filed With SEC on May 3, 2023)
- Amendment No. 1 to Pacira BioSciences, Inc. Deferred Compensation Plan (Filed With SEC on February 28, 2023)
- Executive Employment Agreement, dated May 4, 2020, between the Registrant and Jonathan Slonin (Filed With SEC on May 4, 2022)
- Form of Nonstatutory Stock Option Agreement (Non-Employee Directors) under the Amended and Restated 2011 Stock Incentive Plan for grants made on or after February 1, 2022 (Filed With SEC on February 28, 2022)
- Form of Nonstatutory Stock Option Agreement (Employees) under the Amended and Restated 2011 Stock Incentive Plan for grants made on or after February 1, 2022 (Filed With SEC on February 28, 2022)
- Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on June 11, 2021)
- Executive Employment Agreement, dated June 1, 2020, between the Registrant and Donald Manning (Filed With SEC on May 4, 2021)
- Pacira BioSciences, Inc. Long-Term Incentive Plan (Filed With SEC on December 7, 2020)
- Pacira BioSciences, Inc. Deferred Compensation Plan (Filed With SEC on June 11, 2020)
- Executive Employment Agreement, dated April 24, 2017, between the Registrant and Roy Winston (Filed With SEC on May 7, 2020)
- Executive Employment Agreement, dated June 19, 2019, between the Registrant and Max Reinhardt (Filed With SEC on May 7, 2020)
- Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on August 8, 2019)
- Amended and Restated 2011 Stock Incentive Plan (Filed With SEC on June 7, 2019)
- Executive Employment Agreement, dated May 29, 2017, between the Registrant and Dennis McLoughlin (Filed With SEC on May 2, 2019)
- Amendment No. 1 to Executive Employment Agreement, dated June 30, 2015, between the Registrant and Richard Scranton, M.D (Filed With SEC on August 2, 2018)
- Executive Employment Agreement, dated March 13, 2013, between the Registrant and Richard Scranton, M.D (Filed With SEC on August 2, 2018)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 4, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2016)
- PACIRA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN (As approved by stockholders on June 14, 2016) (Filed With SEC on June 17, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 2, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 2, 2016)
- FOURTH AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on February 25, 2016)
- PACIRA PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD NOTICE AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN (Filed With SEC on July 30, 2015)
- PACIRA PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT AWARD NOTICE AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN (Filed With SEC on July 30, 2015)
- AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)
- AMENDMENT NO. 2 TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)
- AMENDMENT NO. 2 TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 30, 2015)
